Of note, pyrimethamine mediated lysosomal modification, the release of cathepsin B from lysosomes to the cytoplasm, and the activation of caspase-3 to a greater extent in HCC cells than in hepatocytes (Fig. 5d). Here, CASP3 is linked to hepatocellular carcinoma.